Answer Summary

Members shared their experiences with ovarian cancer recurrence after someone expressed concern about elevated antigen and enzyme levels, with... Read more

Members shared their experiences with ovarian cancer recurrence after someone expressed concern about elevated antigen and enzyme levels, with timelines ranging from just three months to five years after initial treatment, emphasizing that recurrence is unfortunately common with this disease. Several members described their current treatment approaches, including Doxil, Avastin, Keytruda, Lynparza, and a newer targeted antibody called Elahere, while stressing the importance of monitoring CA-125 levels closely and working with a specialized gynecologic oncologist who understands recurrent ovarian cancer. A recurring theme was the emotional weight of living with an aggressive disease that often returns, balanced by a determination to keep fighting, stay informed about new treatments, and find moments of joy despite the challenges.